Literature DB >> 26706415

A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.

Ying Shi1, Junwei Wang2, Yuhe Wang3, Anna Wang1, Hongliang Guo4, Feili Wei1, Sanjay R Mehta3, Stephen Espitia5, Davey M Smith5, Longgen Liu6, Yulin Zhang7, Dexi Chen8.   

Abstract

Hepatitis B virus (HBV) infection-related hepatocellular carcinoma (HCC) represents a major health problem worldwide. HBV X (HBx) protein is the most common open reading frame that may undergo mutations, resulting in the development of HCC. This study aimed to determine specific HBx mutations that differentiate the central- and para-tumor tissues, and identify their association with HCC development. HBx gene from HCC tumor and para-tumor tissues of 47 HCC patients was amplified, sequenced and statistically analyzed. A novel combination of 2 mutations at residues 10 and 144 was identified which might play a significant role in HCC development. Expression vectors carrying HBx with the specific mutations were constructed and transfected into HepG2 and p53-null HepG2 cells. Compared to wild type (WT) and single mutation of HBx at residue 10 or 144, the 10/144 double mutations strongly up-regulated p21 expression and prolonged G1/S transition in WT- and p53-null HepG2 cells. Apoptosis was also inhibited by HBx harboring 10/44 double-mutation. Binding of 10/144 double-mutant HBx to p53 was lower than WT HBx. Conclusively, the 10/144 double mutation of HBx might play a crucial role in HCC formation.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Hepatitis B virus; Hepatocellular carcinoma; Mutation

Mesh:

Substances:

Year:  2015        PMID: 26706415      PMCID: PMC4934374          DOI: 10.1016/j.canlet.2015.12.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  55 in total

Review 1.  Hepatitis B virus genotypes and variants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

Review 2.  Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis.

Authors:  Mark A Feitelson; Jungmin Lee
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

Review 3.  Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.

Authors:  K Matsubara; T Tokino
Journal:  Mol Biol Med       Date:  1990-06

4.  Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.

Authors:  Jun Yong Choi; George K Hightower; Joseph K Wong; Robert Heaton; Steven Woods; Igor Grant; Thomas D Marcotte; Ronald J Ellis; Scott L Letendre; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J Allen McCutchan; Douglas D Richman; Davey M Smith
Journal:  J Neurovirol       Date:  2012-04-13       Impact factor: 2.643

5.  Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.

Authors:  A S Kekulé; U Lauer; L Weiss; B Luber; P H Hofschneider
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

6.  Signature pattern analysis: a method for assessing viral sequence relatedness.

Authors:  B Korber; G Myers
Journal:  AIDS Res Hum Retroviruses       Date:  1992-09       Impact factor: 2.205

7.  Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Authors:  Sameer Parekh; Fabien Zoulim; Sang Hoon Ahn; Adrienne Tsai; Jisu Li; Shigenobu Kawai; Nasser Khan; Christian Trépo; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.

Authors:  Alfred S L Cheng; Jun Yu; Paul B S Lai; Henry L Y Chan; Joseph J Y Sung
Journal:  Biochem Biophys Res Commun       Date:  2008-07-02       Impact factor: 3.575

9.  Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.

Authors:  P Paterlini; K Poussin; M Kew; D Franco; C Brechot
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

10.  Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.

Authors:  Masashi Tatsukawa; Akinobu Takaki; Hidenori Shiraha; Kazuko Koike; Yoshiaki Iwasaki; Haruhiko Kobashi; Shin-Ichi Fujioka; Kohsaku Sakaguchi; Kazuhide Yamamoto
Journal:  BMC Cancer       Date:  2011-10-21       Impact factor: 4.430

View more
  10 in total

Review 1.  Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Giacomo Emanuele Maria Rizzo; Giuseppe Cabibbo; Antonio Craxì
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

2.  Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells.

Authors:  Cuifang Zhang; Ying Xie; Ruixue Lai; Jianhua Wu; Zhanjun Guo
Journal:  J Hepatocell Carcinoma       Date:  2022-05-03

3.  Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling.

Authors:  Shu-Xiang Wu; Wan-Nan Chen; Zhen-Tang Jing; Wei Liu; Xin-Jian Lin; Xu Lin
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

4.  USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.

Authors:  Yu Qian; Boshi Wang; Aihui Ma; Li Zhang; Guiqin Xu; Qi Ding; Tiantian Jing; Lin Wu; Yun Liu; Zhaojuan Yang; Yongzhong Liu
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 5.  Interference of Apoptosis by Hepatitis B Virus.

Authors:  Shaoli Lin; Yan-Jin Zhang
Journal:  Viruses       Date:  2017-08-18       Impact factor: 5.048

6.  Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation Sequencing.

Authors:  Ya Fu; Yongbin Zeng; Tianbin Chen; Huijuan Chen; Ni Lin; Jinpiao Lin; Xiaofeng Liu; Er Huang; Songhang Wu; Shu Wu; Siyi Xu; Long Wang; Qishui Ou
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 7.  Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins.

Authors:  Sanae Hayashi; Katsuya Nagaoka; Yasuhito Tanaka
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

Review 8.  Hepatitis B Virus X Protein and Hepatocarcinogenesis.

Authors:  Shuaichen Liu; Samantha S Y Koh; Caroline G L Lee
Journal:  Int J Mol Sci       Date:  2016-06-14       Impact factor: 5.923

9.  A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.

Authors:  Sujun Sun; Haiyu Ji; Yingying Feng; Yu Kang; Juan Yu; Anjun Liu
Journal:  Cancer Manag Res       Date:  2018-03-05       Impact factor: 3.989

Review 10.  Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma.

Authors:  Ping An; Jinghang Xu; Yanyan Yu; Cheryl A Winkler
Journal:  Front Genet       Date:  2018-07-19       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.